9 results
POS AM
PTPI
Petros Pharmaceuticals Inc
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, the Board were to determine
424B3
PTPI
Petros Pharmaceuticals Inc
14 Jan 22
Prospectus supplement
5:18pm
difficult or to discourage an attempt to gain control of Petros by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due
424B5
PTPI
Petros Pharmaceuticals Inc
23 Dec 21
Prospectus supplement for primary offering
5:01pm
control of Petros by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations
424B5
uj6m8
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
sncnk2o9s68jm6jffo5
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
EX-4.4
mv2tvbh3csil0lg
31 Mar 21
Annual report
4:30pm
S-3
dvo8kfv8jg0dh892cpn
29 Jan 21
Shelf registration
4:48pm
- Prev
- 1
- Next